JPMorgan Upgrades Annexon Biosciences (ANNX) to Overweight, ‘Positive Outlook on ANX005 in GBS & Pipeline Optionality’

Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Annexon+Biosciences+%28ANNX%29+to+Overweight%2C+%27Positive+Outlook+on+ANX005+in+GBS+%26+Pipeline+Optionality%27/22865928.html for the full story.